Fas ligand (FasL), a cell surface molecule belonging to the tumour necrosis family, induces apoptosis through its receptor, Fas antigen (Fas). Germinal centre B cells strongly express Fas, but the role of the Fas-FasL system in B-cell selection in the germinal centre remains unclear. In the present
Fas ligand expression in the germinal centre
โ Scribed by Verbeke, Caroline S.; Wenthe, Ursula; Zentgraf, Hanswalter
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 297 KB
- Volume
- 189
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
โฆ Synopsis
Whereas the importance of the Fas/FasL system in the regulation of T-cell homeostasis is well established, it is not yet clear if FasL is involved in B-cell regulation, especially in the clonal selection of B lymphocytes in the germinal centre (GC). This study therefore investigated the expression of FasL protein in tonsils and lymph nodes with lymphofollicular hyperplasia by western blotting and immunohistochemistry. In all the samples examined, western blot analysis showed FasL proteins of 33 and 52 kD, which presumably correspond to membrane-bound and soluble forms of the FasL protein. Immunohistochemically, FasL was found in a limited number of cells confined to a cluster in the light zone of the GC. The signal showed a delicate meshwork-like pattern of branching processes enmeshing the centrocytes and the few centroblasts of the light zone. In serial sections, the immunostaining pattern for FasL was found largely to coincide with the CD23 staining of follicular dendritic cells (FDCs), which are typically located in the light zone. In contrast, the FasL signal did not correspond to the distribution of the CD4-positive GC T-cells. In conclusion, expression of FasL in lymphofollicular hyperplasia seems to be largely confined to the light zone of the GCs, where selection of FDC-associated centrocytes is known to occur. These observations thus suggest that FasL is involved in selection processes of the B-cell system.
๐ SIMILAR VOLUMES
Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
## BACKGROUND. Although esophageal adenocarcinomas (EADCA) have been shown to have substantially reduced or absent Fas expression, the status of Fas ligand (FasL) in these tumors, especially adenocarcinomas, is largely unknown. ## METHODS. Using immunohistochemistry, the authors investigated FasL
## Background and objectives: Fas ligand (fasl) is expressed in many cancers and plays an important role in establishing immunologically privileged environments that allow tumors to escape the host's immune surveillance. we investigate the expression of fasl in human colorectal cancer and colorecta